RUA Life Sciences plc (FRA:AOHA)

Market Cap	9.13M +1.0%
Revenue (ttm)	5.11M +74.5%
Net Income	-166.50K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	659
Open	0.1080
Previous Close	0.1080
Day's Range	0.1080 - 0.1080
52-Week Range	0.0815 - 0.1900
Beta	n/a
RSI	37.42
Earnings Date	Jun 25, 2026

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also enga...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1996
• Employees: 59
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AOHA

Financial Performance

Financial numbers in GBP